Latest Skyline Medical Installations Reinforce Increasing Standardization of Safer Closed Fluid Waste Management System
Category: Baystreet Newswire
Company: Accesswire-MRM
ID: 421594
Date: Thursday, October 16, 2014
Ticker: OTC:BB:SKLN
Customers Continue Trend of Multi-Site STREAMWAY(R) System Installations
EAGAN, MN / ACCESSWIRE / October 16, 2014 / Skyline Medical Inc. (OTCQB: SKLN) recently completed the installation of 17 STREAMWAY Systems, with the majority for repeat customers.
"We're noticing a standardization of our technology within our customer base," said Josh Kornberg, CEO of Skyline Medical. "More than 85% of our customers have more than one STREAMWAY unit, and we fully expect that trend to continue."
"With the current Ebola epidemic, the safety of our closed system is more salient than ever," Kornberg explained. "Unlike traditional canister and cart systems, STREAMWAY is fully automated to reduce the risk of exposure to patient body fluids."
As previously announced the recent STREAMWAY installations include existing customer healthcare facilities in numerous states: Arizona, Florida, Minnesota, New York, Tennessee, Texas and Wisconsin.
"Our national sales force has made strong progress the past few months," Kornberg said. "We're especially pleased with the conversion rate on our demos and trials: 90% of demos and trials have resulted in sales. I'm excited about our future and look forward to continued sales growth as we convert even more healthcare facilities to the STREAMWAY System."
About Skyline Medical Inc.:
Skyline Medical Inc. produces a fully automated, patented, FDA-cleared, waste fluid disposal system that virtually eliminates staff exposure to blood, irrigation fluid and other potentially infectious fluids found in the healthcare environment. Antiquated manual fluid handling methods - which require hand carrying and emptying filled fluid canisters - present an exposure risk and potential liability. Skyline Medical's STREAMWAY System fully automates the collection, measurement and disposal of waste fluids and is designed to: 1) reduce overhead costs to hospitals and surgical centers, 2) improve compliance with Occupational State and Health Association (OSHA) and other regulatory agency safety guidelines, 3) improve efficiency in the operating room, and
radiology and endoscopy departments - leading to greater profitability, and 4) provide greater environmental stewardship by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United States. For additional information, please visit: www.skylinemedical.com.
Forward-Looking Statements:
Certain of the matters discussed in this announcement contain forward-looking statements that involve material risks to and uncertainties in the company's business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include, among other things, inability to raise sufficient additional capital to operate our business; approximately $3.4 million in debts, liabilities and cash obligations that predominantly become due in calendar 2014; unexpected costs and operating deficits, and lower than expected sales and revenues, if any; uncertain willingness and ability of customers to adopt new technologies and other factors that may affect further market acceptance, if our product is not accepted by our potential customers, it is unlikely that we will ever become profitable, adverse economic
conditions; adverse results of any legal proceedings; the volatility of our operating results and financial condition; inability to attract or retain qualified senior management personnel, including sales and marketing personnel; our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed
from time to time in the Company's reports filed with the Securities and Exchange Commission, which are available for review at www.sec.gov. This is not a solicitation to buy or sell securities and does not purport to be an analysis of the company's financial position. See the Company's most recent Annual Report on Form 10-K, and subsequent reports and other filings at www.sec.gov.
CONTACT:
Skyline Investor Relations Contacts:
Phil Carlson / Elizabeth BarkerKCSA Strategic Communications
212-896-1233 / 212-896-1203
skyline@kcsa.com
SOURCE: Skyline Medical Inc.
